Dr. Olivier Clément, PhD, and Dr. Pierre-Henri Lefevre[email protected]Clinical NewsGadolinium chelates for MRI: Where are we now?The safety of MRI contrast agents came under close scrutiny at the Journées Francophones de Radiologie congress. Dr. Olivier Clément, PhD, from Paris and Dr. Pierre-Henri Lefevre from Nîmes provided timely summaries of the current and future status of these products and asked what the literature tells us.October 17, 2016Page 1 of 1Top StoriesCTNew evidence emerges on U.K. radiology’s workforce crisisTwo major reports published today reveal the huge workforce problems facing the U.K. radiology and oncology sectors and the ever-greater reliance on outsourcing.Artificial IntelligenceBarcelona radiomics team reveals AI progress in liver cancerArtificial IntelligenceMomentum builds for AI use in intracranial hemorrhage casesArtificial IntelligenceHot shots from Wiesbaden: RöKo 2025 picture gallerySponsor ContentJoin us on 17 June for a webinar